Deutsche Bank picks the currencies that could soon hit new highs on vaccine breakthroughs

Scott Kanowsky
Small bottles labeled with a "Vaccine COVID-19" sticker and a medical syringe are seen in this illustration taken taken April 10, 2020.
Dado Ruvic | Reuters

Several emerging market currencies could hit fresh highs before the end of 2020 due to the optimism surrounding coronavirus vaccines, according to new research from Deutsche Bank.

The German lender expects a Covid-19 shot from British pharma giant Astrazeneca and Oxford University will be more affordable for lower and middle-income countries, thanks in part to cheaper costs of production and distribution.

Earlier this week, interim results from clinical trials found the Oxford-Astrazeneca vaccine had an average efficacy of 70% in protecting against the virus. When the dosing regimen was tweaked, researchers added that the figure could climb to as high as 90%.

More In Pro News and Analysis

CNBC ProGoldman, Morgan Stanley and JPMorgan make the case for higher valuations by separating from the pack
CNBC ProMike Santoli’s market notes: Rally out of sideways pause, Netflix reminds us that tech is thriving
CNBC ProJim Chanos is no longer short Tesla, but he's still betting against the stock